Aristocort and Weakness - a phase IV clinical study of FDA data

Summary:

Weakness is reported as a side effect among people who take Aristocort (triamcinolone), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Synthroid, and have Burkitt lymphoma.

The phase IV clinical study analyzes which people have Weakness when taking Aristocort. It is created by eHealthMe based on reports of 505 people who have side effects when taking Aristocort from the FDA, and is updated regularly.

What is Aristocort?

Aristocort has active ingredients of triamcinolone. eHealthMe is studying from 508 Aristocort users. Check the latest studies of Aristocort.

What is Weakness?

Weakness is found to be associated with 3,639 drugs and 6,612 conditions by eHealthMe. Check the latest studies of Weakness.

On Jul, 17, 2026

505 people reported to have side effects when taking Aristocort.
Among them, 30 people (5.94%) have Weakness.

Among these 30 people:

How long have people been on Aristocort when they have Weakness? *

What is the gender of people who have Weakness when taking Aristocort? *

female: 24.14 %
male: 75.86 %

What is the age of people who have Weakness when taking Aristocort? *

What are other drugs people take besides Aristocort? *

What are other side effects people have besides Weakness? *

Fall: 20 people, 66.67%
Fatigue (feeling of tiredness): 15 people, 50.00%
Diarrhea: 12 people, 40.00%
Weight Decreased: 11 people, 36.67%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 11 people, 36.67%
Dehydration (dryness resulting from the removal of water): 11 people, 36.67%
Mobility Decreased (ability to move is reduced): 10 people, 33.33%
Activities Of Daily Living Impaired: 8 people, 26.67%
Thrombocytopenia (decrease of platelets in blood): 7 people, 23.33%
Autonomic Nervous System Imbalance (autonomic nervous system is of net equal emphasis): 6 people, 20.00%

What are the existing conditions these people have? *

Burkitt Lymphoma (cancer of the lymphatic system): 9 people, 30.00%
Tendonitis (a condition that causes pain and swelling of tendons): 4 people, 13.33%
Peripheral T-Cell Lymphoma Unspecified (peripheral t-cell cancer unspecified): 3 people, 10.00%
Non-Hodgkin's Lymphoma Unspecified Histology Indolent (malignant (cancer) cells form in the lymph system- unspecified histology indolent): 2 people, 6.67%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 2 people, 6.67%
Hepatitis B: 2 people, 6.67%
High Blood Pressure: 1 person, 3.33%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 1 person, 3.33%
Diabetes: 1 person, 3.33%
Diarrhea: 1 person, 3.33%

* Approximation only. Some reports may have incomplete information.

Do you take Aristocort and have Weakness?

- Check whether Weakness is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Aristocort:

Aristocort (508 reports)

Weakness treatments and more:

Weakness (586,876 reports)

Browse all side effects of Aristocort:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Weakness:

Weakness (3,639 drugs)

Browse all the conditions that are associated with Weakness:

Weakness (6,612 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on triamcinolone (the active ingredients of Aristocort) and Aristocort (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.